News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Coulie Bernard
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/19/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/18/2023 |
4
| Coulie Bernard (President and CEO) has filed a Form 4 on PLIANT THERAPEUTICS, INC.|
Txns:
| Granted 137,500 shares
@ $0 |
|
| 04/03/2023 |
4
| Coulie Bernard (President and CEO) has filed a Form 4 on PLIANT THERAPEUTICS, INC.|
Txns:
| Sold 35,339 shares
@ $26.5209, valued at
$937.2k
|
|
| 03/31/2023 |
4
| Coulie Bernard (President and CEO) has filed a Form 4 on PLIANT THERAPEUTICS, INC.|
Txns:
| Granted 68,749 shares
@ $0 |
|
| 02/06/2023 |
4
| Coulie Bernard (President and CEO) has filed a Form 4 on PLIANT THERAPEUTICS, INC.|
Txns:
| Sold 13,395 shares
@ $34.1265, valued at
$457.1k
Sold 1,605 shares
@ $34.9566, valued at
$56.1k
Sold 9,738 shares
@ $33.3629, valued at
$324.9k
Sold 5,262 shares
@ $34.0768, valued at
$179.3k
Exercised 15,000 options to buy
@ $6.22, valued at
$93.3k
Exercised 15,000 options to buy
@ $6.22, valued at
$93.3k
|
|
| 02/01/2023 |
4
| Coulie Bernard (President and CEO) has filed a Form 4 on PLIANT THERAPEUTICS, INC.|
Txns:
| Sold 11,395 shares
@ $33.9778, valued at
$387.2k
Sold 3,605 shares
@ $34.657, valued at
$124.9k
Sold 15,000 shares
@ $34.917, valued at
$523.8k
Sold 9,455 shares
@ $34.145, valued at
$322.8k
Sold 5,440 shares
@ $34.778, valued at
$189.2k
Sold 105 shares
@ $35.5548, valued at
$3.7k
Exercised 15,000 options to buy
@ $2.08, valued at
$31.2k
Exercised 10,539 options to buy
@ $2.08, valued at
$21.9k
Exercised 4,461 options to buy
@ $6.22, valued at
$27.7k
Exercised 15,000 options to buy
@ $6.22, valued at
$93.3k
|
|
| 01/27/2023 |
4
| Coulie Bernard (President and CEO) has filed a Form 4 on PLIANT THERAPEUTICS, INC.|
Txns:
| Granted 146,300 shares
@ $0
Sold 15,000 shares
@ $35.2911, valued at
$529.4k
Sold 15,000 shares
@ $35.095, valued at
$526.4k
Exercised 15,000 shares
@ $2.08, valued at
$31.2k
Sold 8,698 shares
@ $35.4157, valued at
$308k
Sold 6,302 shares
@ $36.0589, valued at
$227.2k
Sold 9,779 shares
@ $35.0913, valued at
$343.2k
Sold 221 shares
@ $36.64, valued at
$8.1k
Granted 206,300 options to buy
@ $34.65, valued at
$7.1M
Exercised 15,000 options to buy
@ $2.08, valued at
$31.2k
|
|
| 01/25/2023 |
4
| Coulie Bernard (President and CEO) has filed a Form 4 on PLIANT THERAPEUTICS, INC.|
Txns:
| Sold 10,150 shares
@ $33.7106, valued at
$342.2k
Sold 4,850 shares
@ $34.9288, valued at
$169.4k
Sold 15,000 shares
@ $35, valued at
$525k
Sold 15,000 shares
@ $30.8926, valued at
$463.4k
Sold 13,304 shares
@ $32.4006, valued at
$431.1k
Sold 1,696 shares
@ $33.2897, valued at
$56.5k
Exercised 15,000 options to buy
@ $2.08, valued at
$31.2k
Exercised 15,000 options to buy
@ $2.08, valued at
$31.2k
Exercised 15,000 options to buy
@ $2.08, valued at
$31.2k
|
|
| 01/09/2023 |
4
| Coulie Bernard (President and CEO) has filed a Form 4 on PLIANT THERAPEUTICS, INC.|
Txns:
| Sold 15,000 shares
@ $19.0389, valued at
$285.6k
Sold 5,000 shares
@ $19.1658, valued at
$95.8k
Exercised 15,000 options to buy
@ $2.08, valued at
$31.2k
Exercised 5,000 options to buy
@ $2.08, valued at
$10.4k
|
|
| 01/05/2023 |
4
| Coulie Bernard (President and CEO) has filed a Form 4 on PLIANT THERAPEUTICS, INC.|
Txns:
| Sold 15,000 shares
@ $19.3301, valued at
$290k
Sold 15,000 shares
@ $19.0627, valued at
$285.9k
Exercised 15,000 options to buy
@ $2.08, valued at
$31.2k
Exercised 15,000 options to buy
@ $2.08, valued at
$31.2k
|
|
| 12/21/2022 |
4
| Coulie Bernard (President and CEO) has filed a Form 4 on PLIANT THERAPEUTICS, INC.|
Txns:
| Granted 68,751 shares
@ $0
Sold 34,212 shares
@ $19.1024, valued at
$653.5k
|
|
| 09/14/2022 |
4
| Coulie Bernard (President and CEO) has filed a Form 4 on PLIANT THERAPEUTICS, INC.|
Txns:
| Sold 12,502 shares
@ $22.5445, valued at
$281.9k
Exercised 12,502 options to buy
@ $2.08, valued at
$26k
|
|
| 07/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2022 |
4
| Coulie Bernard (President and CEO) has filed a Form 4 on PLIANT THERAPEUTICS, INC.|
Txns:
| Granted 440,000 options to buy
@ $11.86, valued at
$5.2M
|
|
| 06/15/2021 |
4
| Coulie Bernard (President and CEO) has filed a Form 4 on PLIANT THERAPEUTICS, INC.|
Txns:
| Sold 3,757 shares
@ $32.9827, valued at
$123.9k
Sold 243 shares
@ $33.6888, valued at
$8.2k
|
|
| 04/15/2021 |
4
| Coulie Bernard (President and CEO) has filed a Form 4 on PLIANT THERAPEUTICS, INC.|
Txns:
| Sold 3,500 shares
@ $30.3318, valued at
$106.2k
Exercised 6,000 options to buy
@ $2.08, valued at
$12.5k
|
|
| 03/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/26/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/16/2020 |
4
| Coulie Bernard (President and CEO) has filed a Form 4 on PLIANT THERAPEUTICS, INC.|
Txns:
| Sold 3,163 shares
@ $27.3164, valued at
$86.4k
Sold 337 shares
@ $27.8587, valued at
$9.4k
|
|
| 06/09/2020 |
4
| Coulie Bernard (President and CEO) has filed a Form 4 on PLIANT THERAPEUTICS, INC.|
Txns:
| Exercised 613 shares
@ $6.22, valued at
$3.8k
Exercised 48,227 shares
@ $2.08, valued at
$100.3k
Converted 25,397 shares
@ $0
Granted 377,336 options to buy
@ $0
Exercised 613 options to buy
@ $0
Exercised 48,227 options to buy
@ $0
Converted 181,594 preferred shares
@ $0 |
|
|
|